457 related articles for article (PubMed ID: 17985605)
21. Diagnostic and therapeutic evaluation of community-acquired methicillin-resistant Staphylococcus Aureus (MRSA) skin and soft tissue infections in the emergency department.
Walraven CJ; Lingenfelter E; Rollo J; Madsen T; Alexander DP
J Emerg Med; 2012 Apr; 42(4):392-9. PubMed ID: 21524884
[TBL] [Abstract][Full Text] [Related]
22. Emergence of community-acquired methicillin-resistant Staphylococcus aureus soft tissue infections.
Olesevich M; Kennedy A
J Pediatr Surg; 2007 May; 42(5):765-8. PubMed ID: 17502179
[TBL] [Abstract][Full Text] [Related]
23. Treatment and prevention of community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections.
Popovich KJ; Hota B
Dermatol Ther; 2008; 21(3):167-79. PubMed ID: 18564247
[TBL] [Abstract][Full Text] [Related]
24. Therapies and vaccines for emerging bacterial infections: learning from methicillin-resistant Staphylococcus aureus.
John CC; Schreiber JR
Pediatr Clin North Am; 2006 Aug; 53(4):699-713. PubMed ID: 16873000
[TBL] [Abstract][Full Text] [Related]
25. Therapy-resistant skin and soft tissue infections caused by community-acquired methicillin-resistant Staphylococcus aureus in a young immunocompetent adult.
Graue N; Korber A; Schmid EN; Rath PM; Dissemond J
J Eur Acad Dermatol Venereol; 2008 Jun; 22(6):766-7. PubMed ID: 18482040
[No Abstract] [Full Text] [Related]
26. Bactericidal activity of orally available agents against methicillin-resistant Staphylococcus aureus.
Kaka AS; Rueda AM; Shelburne SA; Hulten K; Hamill RJ; Musher DM
J Antimicrob Chemother; 2006 Sep; 58(3):680-3. PubMed ID: 16840428
[TBL] [Abstract][Full Text] [Related]
27. Community-associated methicillin-resistant Staphylococcus aureus: new bug, old drugs.
Sabol KE; Echevarria KL; Lewis JS
Ann Pharmacother; 2006 Jun; 40(6):1125-33. PubMed ID: 16735661
[TBL] [Abstract][Full Text] [Related]
28. Community-acquired methicillin-resistant Staphylococcus aureus infections of the hand: prevalence and timeliness of treatment.
O'Malley M; Fowler J; Ilyas AM
J Hand Surg Am; 2009 Mar; 34(3):504-8. PubMed ID: 19258149
[TBL] [Abstract][Full Text] [Related]
29. The emergence of severe, community-acquired methicillin-resistant Staphylococcus aureus infections.
Crum NF
Scand J Infect Dis; 2005; 37(9):651-6. PubMed ID: 16126565
[TBL] [Abstract][Full Text] [Related]
30. Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) skin infections.
Odell CA
Curr Opin Pediatr; 2010 Jun; 22(3):273-7. PubMed ID: 20386450
[TBL] [Abstract][Full Text] [Related]
31. Skin and soft-tissue infections caused by community-acquired methicillin-resistant Staphylococcus aureus.
Stryjewski ME; Chambers HF
Clin Infect Dis; 2008 Jun; 46 Suppl 5():S368-77. PubMed ID: 18462092
[TBL] [Abstract][Full Text] [Related]
32. Community-associated methicillin-resistant Staphylococcus aureus: risk factors for infection, and long-term follow-up.
Longtin Y; Sudre P; François P; Schrenzel J; Aramburu C; Pastore R; Gervaix A; Renzi G; Pittet D; Harbarth S
Clin Microbiol Infect; 2009 Jun; 15(6):552-9. PubMed ID: 19416294
[TBL] [Abstract][Full Text] [Related]
33. Antibiotic options for treating community-acquired MRSA.
Powell JP; Wenzel RP
Expert Rev Anti Infect Ther; 2008 Jun; 6(3):299-307. PubMed ID: 18588495
[TBL] [Abstract][Full Text] [Related]
34. Community-associated MRSA (CA-MRSA): an emerging pathogen in infective endocarditis.
Millar BC; Prendergast BD; Moore JE
J Antimicrob Chemother; 2008 Jan; 61(1):1-7. PubMed ID: 17962214
[TBL] [Abstract][Full Text] [Related]
35. Comparison of both clinical features and mortality risk associated with bacteremia due to community-acquired methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus.
Wang JL; Chen SY; Wang JT; Wu GH; Chiang WC; Hsueh PR; Chen YC; Chang SC
Clin Infect Dis; 2008 Mar; 46(6):799-806. PubMed ID: 18266610
[TBL] [Abstract][Full Text] [Related]
36. Increasing rates of community-acquired methicillin-resistant Staphylococcus aureus infections among HIV-infected persons.
Crum-Cianflone NF; Burgi AA; Hale BR
Int J STD AIDS; 2007 Aug; 18(8):521-6. PubMed ID: 17686212
[TBL] [Abstract][Full Text] [Related]
37. Community-acquired methicillin resistant Staphylococcus aureus skin infection.
Halem M; Trent J; Green J; Kerdel F
Semin Cutan Med Surg; 2006 Jun; 25(2):68-71. PubMed ID: 16908395
[TBL] [Abstract][Full Text] [Related]
38. A useful clinical approach to community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) infections.
Cunha BA
J Hosp Infect; 2008 Mar; 68(3):271-3. PubMed ID: 18289722
[No Abstract] [Full Text] [Related]
39. Community associated MRSA: an alert to paediatricians.
Jeyaratnam D; Reid C; Kearns A; Klein J
Arch Dis Child; 2006 Jun; 91(6):511-2. PubMed ID: 16714723
[TBL] [Abstract][Full Text] [Related]
40. Cutaneous community-acquired methicillin-resistant Staphylococcus aureus infection in participants of athletic activities.
Cohen PR
South Med J; 2005 Jun; 98(6):596-602. PubMed ID: 16004165
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
